000 | 01153 a2200325 4500 | ||
---|---|---|---|
005 | 20250515125411.0 | ||
264 | 0 | _c20081014 | |
008 | 200810s 0 0 eng d | ||
022 | _a1462-0332 | ||
024 | 7 |
_a10.1093/rheumatology/ken243 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSilva, L | |
245 | 0 | 0 |
_aRepairing erosions in rheumatoid arthritis. A realistic goal. _h[electronic resource] |
260 |
_bRheumatology (Oxford, England) _cSep 2008 |
||
300 |
_a1432-3 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
650 | 0 | 4 | _aEtanercept |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xtherapeutic use |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xetiology |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
700 | 1 | _aFernández-Castro, M | |
700 | 1 | _aAndreu, J-L | |
773 | 0 |
_tRheumatology (Oxford, England) _gvol. 47 _gno. 9 _gp. 1432-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/ken243 _zAvailable from publisher's website |
999 |
_c18088839 _d18088839 |